Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
Status:
Completed
Trial end date:
2017-11-07
Target enrollment:
Participant gender:
Summary
The Pilot study is designed to evaluate the overall safety and feasibility of a strategy
based on subcutaneous delivery of furosemide. It will be used to inform the subsequent
evaluation phase of the study (separate protocol). The primary objective of the study is to
determine if a strategy of a novel subcutaneous delivery of furosemide is safe and feasible
in patients with acute heart failure.